Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103214429A reveals efficient grinding method for antibacterial intermediates, offering cost-effective and scalable production solutions for global pharma.
Patent CN114573500B reveals a safer route for raffinancin intermediate. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Patent CN104418775B details palladium-catalyzed asymmetric hydrogenolysis for high-purity chiral amine production offering significant supply chain and cost advantages.
Patent CN104803898A enables mild visible light catalysis for aryl sulfides. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel zinc-catalyzed route for high-purity chiral bisphosphonamides offering scalable manufacturing solutions for asymmetric catalysis applications in pharma.
Patent CN107641100A details a mild copper-catalyzed route for 6-cyanophenanthridine. This method offers significant supply chain stability and cost advantages for pharmaceutical manufacturing.
Patent CN102206189A details a green copper-catalyzed route for phenazine derivatives in water, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN107383005B reveals a green one-step synthesis for high-purity Zolpidem intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN116082152B reveals a novel photocatalytic route for ethyl pyruvate. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110698451A reveals a novel P2O5 cyclization method for Baloxavir intermediates. Achieve high purity, low waste, and cost reduction in API manufacturing.
Patent CN110981707A details a novel isomerization method for high-purity chiral citronellal. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN1974567B details a safer, scalable synthesis of Sertaconazole Nitrate using NaOH/Isopropanol, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel 4-step synthesis of Idelalisib eliminates metal residues and reduces costs. Ideal for reliable API intermediate suppliers seeking green manufacturing.
Patent CN104592222B reveals a cost-effective AZD6482 route using chiral sulfinamide. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN113336792B reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonate compounds, offering superior stereoselectivity and scalable manufacturing for NASH therapeutics.
Patent CN104557737B details a high-yield Pd-catalyzed route for quinazoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105541685B reveals high-yield iridium-catalyzed trifluoromethylation. Delivers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed route for polyaryl sulfone intermediates offers safer processing and significant cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN110922305A reveals a novel route for 5-bromo-2-chloro-4'-ethoxy diphenylmethane, eliminating ortho-impurities and ensuring high-purity API intermediates.
Novel room-temperature mesylation route for Ertapenem side chain. Reduces cryogenic costs and simplifies purification for scalable API manufacturing.